These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 9257080)

  • 21. Antiarrhythmic drugs in patients with implantable cardioverter-defibrillators.
    Bollmann A; Husser D; Cannom DS
    Am J Cardiovasc Drugs; 2005; 5(6):371-8. PubMed ID: 16259525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of sudden cardiac death.
    Goldberger JJ
    Heart Dis; 2000; 2(4):305-13. PubMed ID: 11728274
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Delayed and indirect effects of antiarrhythmic drugs in reducing sudden cardiac death.
    Malhotra S; Das MK
    Future Cardiol; 2011 Mar; 7(2):203-17. PubMed ID: 21453027
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Secondary prevention after myocardial infarction with class III antiarrhythmic drugs.
    Ceremuzyński L
    Am J Cardiol; 1993 Nov; 72(16):82F-86F. PubMed ID: 8237835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. What can we expect from prophylactic implantable defibrillators?
    Wilber DJ; Kall JG; Kopp DE
    Am J Cardiol; 1997 Sep; 80(5B):20F-27F. PubMed ID: 9291446
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amiodarone and post-MI patients.
    Nademanee K; Singh BN; Stevenson WG; Weiss JN
    Circulation; 1993 Aug; 88(2):764-74. PubMed ID: 7687937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sudden death due to cardiac arrhythmias.
    Huikuri HV; Castellanos A; Myerburg RJ
    N Engl J Med; 2001 Nov; 345(20):1473-82. PubMed ID: 11794197
    [No Abstract]   [Full Text] [Related]  

  • 28. [Arrhythmia risk stratification in patients with heart failure according to drug treatment and its effects].
    Gronda E; Mangiavacchi M; Andreuzzi B; Municinò A
    Ital Heart J Suppl; 2001 Dec; 2(12):1278-83. PubMed ID: 11838348
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of antiarrhythmic drugs: frequent implantable cardioverter-defibrillator shocks, risk of proarrhythmia, and new drug therapy.
    Droogan C; Patel C; Yan GX; Kowey PR
    Heart Fail Clin; 2011 Apr; 7(2):195-205, viii. PubMed ID: 21439498
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prophylactic implantable cardioverter defibrillator therapy in high-risk patients with coronary artery disease.
    Kolettis TM; Saksena S
    Am Heart J; 1994 Apr; 127(4 Pt 2):1164-70. PubMed ID: 7909188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Heart failure].
    Yonezawa M; Komuro I
    Nihon Rinsho; 2002 Jul; 60(7):1422-6. PubMed ID: 12136624
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators.
    Buxton AE; Lee KL; Fisher JD; Josephson ME; Prystowsky EN; Hafley G
    N Engl J Med; 1999 Dec; 341(25):1882-90. PubMed ID: 10601507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of the implantable cardioverter-defibrillator for prevention of sudden cardiac death.
    Josephson ME; Callans DJ; Buxton AE
    Ann Intern Med; 2000 Dec; 133(11):901-10. PubMed ID: 11103061
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment and prevention of sudden cardiac death: effect of recent clinical trials.
    Goldberger JJ
    Arch Intern Med; 1999 Jun; 159(12):1281-7. PubMed ID: 10386504
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SCD-HeFT: Use of R-R interval statistics for long-term risk stratification for arrhythmic sudden cardiac death.
    Au-Yeung WT; Reinhall PG; Poole JE; Anderson J; Johnson G; Fletcher RD; Moore HJ; Mark DB; Lee KL; Bardy GH
    Heart Rhythm; 2015 Oct; 12(10):2058-66. PubMed ID: 26096609
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical management and prevention of sudden cardiac death.
    Yousuf O; Chrispin J; Tomaselli GF; Berger RD
    Circ Res; 2015 Jun; 116(12):2020-40. PubMed ID: 26044254
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Acute myocardial ischemia and ventricular arrhythmias in the pathogenesis of sudden cardiac death in coronary disease].
    Zehender M; Faber T; Brunner M; Grom A
    Z Kardiol; 2000; 89 Suppl 3():13-23. PubMed ID: 10810781
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of hypertrophic cardiomyopathy in children.
    Seggewiss H; Rigopoulos A
    Paediatr Drugs; 2003; 5(10):663-72. PubMed ID: 14510624
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of amiodarone in the era of the implantable cardioverter defibrillator.
    Dorian P; Mangat I
    J Cardiovasc Electrophysiol; 2003 Sep; 14(9 Suppl):S78-81. PubMed ID: 12950525
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A guide to device selection: cardiac resynchronization therapy alone or in combination with an implantable cardioverter defibrillator.
    Prystowsky EN
    Rev Cardiovasc Med; 2003; 4 Suppl 2():S47-54. PubMed ID: 12776013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.